Insurance coverage of weight loss drugs, state by state

Insurance covers some of the costs for GLP-1 drugs for weight loss for around 1 in 4 Americans, according to data from Leverage and the Robert Wood Johnson Foundation.

Data from Leverage, a consulting firm, accounts for around 89% of insured lives in the U.S. 

In five states, more than half of insured individuals have some insurance coverage for new-generation weight-loss drugs, including GLP-1s. 

GLP-1 drugs approved for weight loss include Wegovy, Saxenda and Zepbound. The drugs can be expensive, costing more than $1000 a month. 

In seven states fewer than 1 in 10 have insurance coverage for new-generation weight-loss drugs, including GLP-1s. 

Here is the percentage of insured individuals with coverage for weight loss drugs in each state: 

1. Delaware: 64.4%
2. Connecticut: 60%
3. Massachusetts: 56.6%
4. Pennsylvania: 53.9%
5. Rhode Island: 51.1%
6. California: 48.1%
7. Virginia: 44.9%
8. Michigan: 43.4%
9. Minnesota: 42.8%
10. Mississippi: 41.4%
11. New Hampshire: 40.7%
12. Kansas: 40.6%
13. Wisconsin: 36.7%
14. New Jersey: 28.4%
15. Alaska: 21.2%
16. Georgia: 20.9%
17. New York: 19.8%
18. Maine: 18.7%
19. Wyoming: 17.6%
20. Kentucky: 17.5%
21. Maryland: 17.3%
22. Hawaii: 16.1%
23. Washington: 15.7%
24. New Mexico: 15.6%
25. Ohio: 15.5%
26. Utah: 14%
27. Colorado: 14.5%
28. Missouri: 14.5%
29. Idaho: 13.8%
30. Texas: 13.5%
31. Indiana: 13.5%
32. West Virginia: 13.4%
33. Illinois: 13%
34. Tennessee: 12.9%
35. North Dakota: 12.1%
36. Alabama: 11.9%
37. North Carolina: 11.6%
38. Nebraska: 11.1%
39. Oklahoma: 10.9%
40. South Dakota: 11%
41. Nevada: 11.3%
42. Florida: 10.6%
43. District of Columbia: 10.2%
44. South Carolina: 10.1%
45. Montana: 9.3%
46. Arizona: 9%
47. Oregon: 8.9%
48. Louisiana: 8.2%
49. Iowa: 6.9%
50. Vermont: 6.1%
51. Arkansas: 4.9%